MedPath

MINT-NADOLOL

MINT-NADOLOL

Approved
DIN Number

02496380

Drug Class

Human

Market Date

Jul 21, 2020

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02496380
AIG Number0113396003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AA12 NADOLOL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NADOLOLActive
Strength: 40 MG
Monograph: NADOLOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.